Capitalsquare Financial Services Private Limited has disclosed a substantial acquisition of shares in Hannah Joseph Hospital Ltd, increasing its total shareholding to 5.12% through market making operations. The disclosure was made on 07 March 2026 in compliance with SEBI regulations governing substantial acquisitions.

Acquisition Details

Capitalsquare Financial Services, acting in its capacity as a market maker, completed the acquisition through open market transactions dated 02 February 2026. The company acquired 8,62,000 equity shares, representing 3.80% of Hannah Joseph Hospital's equity share capital.

Shareholding Pattern Changes

The acquisition significantly altered Capitalsquare Financial Services' shareholding position in Hannah Joseph Hospital. Prior to this transaction, the company held 3,00,000 equity shares representing 1.32% of the total equity share capital.

Company Information

Hannah Joseph Hospital Ltd is listed on the BSE SME platform. The company's total equity share capital comprises 2,26,98,363 equity shares with a face value of INR 10 each, totaling INR 22,69,83,630. This equity structure remained unchanged following the acquisition.

Regulatory Compliance

The disclosure was made under Regulation 29(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Capitalsquare Financial Services confirmed that it does not belong to the promoter or promoter group of Hannah Joseph Hospital Ltd. The disclosure was signed by Mrs. Geeta Manocha, Director of Capitalsquare Financial Services Private Limited (DIN: 01395697), and submitted to both BSE Limited and the target company's compliance officer.

The acquisition represents a strategic increase in shareholding through legitimate market making activities, with all regulatory requirements being duly fulfilled as per SEBI guidelines.

Hannah Joseph Hospital Limited has issued a formal notification to BSE Limited confirming the continuation of its Company Secretary and Compliance Officer following the recent listing of its equity shares. The communication, dated March 07, 2026, addresses regulatory requirements under SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015.

Regulatory Compliance Notification

The hospital informed BSE that Mr. Yuvaraj Saravanan continues to serve as Company Secretary and Compliance Officer under Regulation 6(1) of SEBI LODR Regulations. This confirmation became necessary following the company's equity shares listing on BSE SME Stock Exchange on February 02, 2026.

Company Secretary Profile

Mr. Yuvaraj Saravanan brings substantial expertise to his role as Company Secretary and Compliance Officer. The notification provides comprehensive details about his professional background and qualifications.

Corporate Governance Framework

The notification demonstrates Hannah Joseph Hospital Limited's commitment to maintaining robust corporate governance standards. The company has ensured compliance with SEBI Master Circular no. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, providing all required details pursuant to Regulation 30 of SEBI LODR Regulations.

The communication was signed by Dr. Mosesjoseph Arunkumar, Managing Director (DIN: 03608603), emphasizing the importance of this regulatory compliance at the highest management level. This formal notification ensures transparency and adherence to listing requirements as the healthcare institution transitions into its role as a publicly listed entity on the BSE SME platform.